Eyepoint pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Contact EyePoint Pharmaceuticals

5 hours ago Eyepointpharma.com

833.393.7646

Contact Us Please provide the following information to contact our team. EyePoint Pharmaceuticals, Inc. 480 Pleasant Street, Suite A-210Watertown, MA 02472United States p. 1.833.EyePoint (1.833.393.7646)f. 617.926.5050

Website: https://eyepointpharma.com/contact/

Category: Contact SupportShow Details ››

Home EyePoint Pharmaceuticals

7 hours ago Eyepointpharma.com

EyePoint Pharmaceuticals utilizes science and innovation to develop new solutions that can create a lifetime worth seeing. Every patient is unique, but all patients have a shared vision of the future. A future of night skies filled with stars, faces of loved ones, and the moments that become memories. EyePoint Pharmaceuticals utilizes science

Website: https://eyepointpharma.com/

Category: Home PhoneShow Details ››

Investor Relations Home EyePoint Pharmaceuticals

6 hours ago Investors.eyepointpharma.com

781-575-2879

Transfer Agent: Computershare Investor Services P.O. Box 43078 Providence, RI 02940 USA Phone: 781-575-2879 Fax: 781-575-3605

Website: http://investors.eyepointpharma.com/

Category: Phone Number, Home PhoneShow Details ››

EyePoint Pharmaceuticals Overview, News & Competitors

5 hours ago Zoominfo.com

EyePoint Pharmaceuticals to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference WATERTOWN, Mass., May 26, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that …

Website: https://www.zoominfo.com/c/eyepoint-pharmaceuticals-inc/447132967

Category: Contact NumberShow Details ››

EyePoint Home Facebook

Just Now Facebook.com

EyePoint, Newton, Massachusetts. 4.7K likes. EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) is a specialty biopharmaceutical company committed to developing and commercializing innovative

Website: https://www.facebook.com/EyePointPharma/

Category: Home PhoneShow Details ››

Pipeline EyePoint Pharmaceuticals

6 hours ago Eyepointpharma.com

Building on a Proven Platform. our retinal disease–focused pipeline is designed to provide solutions for patients. When it comes to matters of sight, innovation is our vision. We intend to keep transforming the treatment of wet AMD, diabetic retinopathy, retinal vein occlusion, and chronic posterior uveitis.

Website: https://eyepointpharma.com/pipeline/

Category: Contact NumberShow Details ››

News EyePoint Pharmaceuticals

2 hours ago Eyepointpharma.com

021-06-07

News. EyePoint Pharmaceuticals Reports Positive 30-day Safety Results for all Cohorts from the DAVIO Trial of EYP-1901 for wet-AMD. Published on 2021-06-07. Read More. EyePoint Pharmaceuticals Announces New Category III CPT Code for DEXYCU ® Intraocular Suspension, Approved by the American Medical Association. Published on 2021-1-07.

Website: https://eyepointpharma.com/news/

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals LinkedIn

6 hours ago Linkedin.com

EyePoint Pharmaceuticals 5,007 followers on LinkedIn. Delivering Innovation to the Eye™ About EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) is a pharmaceutical company committed to

Website: https://www.linkedin.com/company/eyepointpharmaceuticals

Category: Contact NumberShow Details ››

EYEPOINT PHARMACEUTICALS, INC Number of Employees 2006

6 hours ago Macrotrends.net

EYEPOINT PHARMACEUTICALS, INC number of employees from 2006 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Website: https://www.macrotrends.net/stocks/charts/EYPT/eyepoint-pharmaceuticals,-inc/number-of-employees

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals Announces 1for10 Reverse Stock

5 hours ago Finance.yahoo.com

WATERTOWN, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic

Website: https://finance.yahoo.com/news/eyepoint-pharmaceuticals-announces-1-10-142000477.html

Category: Contact NumberShow Details ››

How to buy EyePoint Pharmaceuticals stock 27 May price $9.83

Just Now Finder.com

However EyePoint Pharmaceuticals's short interest can also be evaluated against the total number of EyePoint Pharmaceuticals stocks, or, against the total number of tradable EyePoint Pharmaceuticals stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float").

Website: https://www.finder.com/ca/buy-eyepoint-pharmaceuticals-stock

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals Inc EYPT Quotes, Financials

5 hours ago Money.usnews.com

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. 101 Number of Employees Contact

Website: https://money.usnews.com/investing/stocks/eypt-eyepoint-pharmaceuticals-inc

Category: Contact SupportShow Details ››

How Do Analysts Perceive EyePoint Pharmaceuticals Inc

5 hours ago Baxterreport.com

The total number of common shares currently owned by the public is 24.73 million. EYPT does have institutional investors; and they hold 68.90% of the stock. EyePoint Pharmaceuticals Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 0 new insider purchases involving 0 shares.

Website: https://baxterreport.com/2021/07/21/how-do-analysts-perceive-eyepoint-pharmaceuticals-inc-eypt/

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals

1 hours ago Eyepointpharmaclass.com

EyePoint Pharmaceuticals. You are not logged in. EyePoint Pharmaceuticals. Home. You are not logged in. Data retention summary

Website: http://eyepointpharmaclass.com/

Category: Home PhoneShow Details ››

EYEPOINT PHARMACEUTICALS, INC. REVERSE SPLIT OPTION

Just Now Infomemo.theocc.com

EyePoint Pharmaceuticals, Inc. (EYPT) has announced a 1-for-10 reverse stock split. As a result of the reverse stock split, each EYPT Common Share will be converted into the right to receive 0.10 (New) EyePoint Pharmaceuticals, Inc. Common Shares. The reverse stock split will become effective before the market open on December 9, 2020.

Website: https://infomemo.theocc.com/infomemos?number=47968

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals Joins Russell 2000® and Russell

8 hours ago Globenewswire.com

EyePoint Pharmaceuticals Joins Russell 2000® and Russell 3000® Index. WATERTOWN, Mass., June 28, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company

Website: https://www.globenewswire.com/news-release/2021/06/28/2253726/0/en/EyePoint-Pharmaceuticals-Joins-Russell-2000-and-Russell-3000-Index.html

Category: Contact NumberShow Details ››

EYPT Stock Eyepoint Pharmaceuticals, Inc. SEC Filings

Just Now Sec.report

Ticker: EYPT. documents---0.00092291831970215. EyePoint Pharmaceuticals, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. EyePoint Pharmaceuticals, Inc is primarely in the business of laboratory analytical instruments. For financial reporting, their fiscal year ends on December 31st.

Website: https://sec.report/Ticker/EYPT

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals : Receives Preliminary Extension

9 hours ago Marketscreener.com

WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced today that the Company expects to receive a nine month extension on DEXYCU's pass-through payment status, which otherwise would expire on March …

Website: https://www.marketscreener.com/quote/stock/EYEPOINT-PHARMACEUTICALS-42591972/news/EyePoint-Pharmaceuticals-Receives-Preliminary-Extension-to-Pass-Through-Payment-Status-for-DEXYCU-35909968/

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals : Announces New Category III CPT

8 hours ago Marketscreener.com

WATERTOWN, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced today that the American Medical Association (AMA) Current Procedural Terminology (CPT) Editorial …

Website: https://www.marketscreener.com/quote/stock/EYEPOINT-PHARMACEUTICALS-42591972/news/EyePoint-Pharmaceuticals-Announces-New-Category-III-CPT-Code-for-DEXYCU-Intraocular-Suspension-A-35764921/

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals : Receives Preliminary Extension

9 hours ago Marketscreener.com

WATERTOWN, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced today that the Company expects to receive a nine month extension on DEXYCU ® ’s pass-through …

Website: https://www.marketscreener.com/quote/stock/EYEPOINT-PHARMACEUTICALS-42591972/news/EyePoint-Pharmaceuticals-Receives-Preliminary-Extension-to-Pass-Through-Payment-Status-for-DEXYCU-35897868/

Category: Contact NumberShow Details ››

First in Human Study to Evaluate the Safety and

7 hours ago Clinicaltrials.gov

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04747197

Website: https://clinicaltrials.gov/ct2/show/NCT04747197

Category: Contact SupportShow Details ››

Paul Ashton, Former Director, President & Chief Executive

8 hours ago Relationshipscience.com

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Website: https://relationshipscience.com/person/paul-ashton-3389682

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals (EYPT) May Report Negative

4 hours ago Zacks.com

For the last reported quarter, it was expected that EyePoint Pharmaceuticals would post a loss of $0.53 per share when it actually produced a loss of $0.50, delivering a surprise of +5.66%.

Website: https://www.zacks.com/stock/news/1769673/eyepoint-pharmaceuticals-eypt-may-report-negative-earnings-know-the-trend-ahead-of-q2-release

Category: Contact NumberShow Details ››

EyePoint Pharmaceuticals Public Company Spotlight at

3 hours ago Youtube.com

Nancy Lurker, President & CEO speaks for EyePoint Pharmaceuticals during the Public Company Spotlight at [email protected] 2019. REGISTER for our next ophthalmology co

Website: https://www.youtube.com/watch?v=nmqBYzX5TRg

Category: Contact NumberShow Details ››

Please leave your comments here:

1. What kind of company is eyepoint pharmaceuticals inc?

EyePoint Pharmaceuticals, Inc., is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders.

2. Where is eyepoint pharmaceuticals in watertown ma?

Investor Relations Home EyePoint Pharmaceuticals, Inc. (www.eyepointpharma.com), headquartered in Watertown, MA, is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders.

3. Where is eyepoint pharmaceuticals in basking ridge nj?

The Company's pipeline leverages its proprietary bioerodible Durasert™ technology for extended intravitreal drug delivery including EYP-1901 targeting wet age-related macular degeneration, diabetic retinopathy and retinal vein occlusion. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts with offices in Basking Ridge, New Jersey.

4. How many eyepoint products are approved by the fda?

EyePoint has developed five products approved by the FDA for, sustained-release delivery of drugs to the eye. EyePoint has a number of products in development that utilize our proven Durasert TM and Verisome Technology platforms ®. Use Up/Down Arrow keys to increase or decrease volume.

Brand New Updated

Wordpress Contact Us Page

Franklin Financial Network

Pulte Homes Customer Service Number

Summit Broadband Customer Service Number

Pharmacy Technician Letter Contact Number

Laureate Education

Steamshipauthority.com

Delta Dental Florida Customer Service Number

Department Of Education Contact Numbers

Smith Micro Software

Openoffice.apache.org

Browse All Brands >>

Popular Brands

Eaton
Engie
Evergy
Eqt